Report Categories
View AllRecent Articles
View All
Mint MIMI Stock Take Exposure Smart Money Flows 20260418
Protagonist Therapeutics PTGX Stock Price Target Hike Investor Interest 20260415
MSAI MultiSensor AI Holdings Inc posts narrower than expected Q4 2025 loss shares rise 41 percent
Perpetua Resources Secures 29B US Loan for Idaho Critical Minerals Project
Stolen Identities Emerge as Primary Driver of Cyberattack Surge
UK Government Announces 120m Support Package for Ceramics Industry
International Students Face Growing Barriers to US Employment Amid Weak Hiring and Immigration Policy Shifts
Astra Microwave Products Surges to Record High on Strong Q4 Earnings Dividend Announcement
COLD Q1 2026 Earnings EPS Surprises to the Upside as Loss Narrows
BTSGU Q1 2026 Earnings Strong EPS Beat but Stock Declines Amidst Limited Revenue Disclosure
FATE Q1 2026 Earnings Narrower Loss Surprises Shares Rally
CDZIP Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 36
EXAS Q4 2025 Earnings Significant EPS Miss Amidst Challenging Quarter
Brown Brown Inc BRO Holds Steady Near Support as Resistance Looms
Accelerant Holdings ARX Gains Momentum Holding Above Key Support Level
Genesco GCO Slips Nearly 3 as Footwear Retail Headwinds Weigh on Sentiment
GrabAGun Digital PEW Slides 073 as Bulls Defend 258 Support
Walmart WMT Positioned as Top Dividend Stock for Retirement Portfolios
AI Reshaping Investment Management Deloitte Report Highlights New Frontier
Home Depot SameStore Sales Catch Up to Lowes Potentially Boosting Stock Performance
JPMorgan Adjusts HP Inc HPQ Price Target Ahead of Upcoming Earnings Report
CREX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines
GLPG Q1 2026 Earnings Significant EPS Beat Driven by Cost Control and Operational Efficiency
Cactus Inc Q1 2026 Earnings EPS Beats Estimates by 86 as Operational Efficiency Shines
Sanmina Q1 2026 Earnings Strong EPS Surge Defies Estimates
Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus
Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues